Brain Cancer Symposium

Brain Cancer Symposium

6:30am MDT

Working Breakfast - Sponsored by The Cure Starts Now Australia

7:30am MDT

The Cure Starts Now Chapter Workshop Alhambra HallBrooke Desserich The Cure Starts Now State of the Charity Alhambra HallBrooke Desserich Medical Advisory Council Workshop (Invitation Only) Oak Room

8:00am MDT

Research Trends: What to Watch in the Next 5 Years Alhambra HallKeith Desserich

8:30am MDT

The Cure Starts Now Chapter Workshop Alhambra Hall

9:50am MDT

Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of DMG Alhambra HallDavid Eisenstat

11:05am MDT

Preclinical Assessment of Efficacy and Specificity of Logic-Gates CAR-T Cell Therapy Alhambra HallSujatha Venkataraman

4:00pm MDT

General Registration Ivor Petrak Room

5:30pm MDT

Welcome Reception Ivor Petrak Room

6:30am MDT

Breakfast available in Foyer

7:30am MDT

Welcome Address Alhambra HallKeith Desserich

7:45am MDT

Review of DIPG Data Collection Efforts Alhambra HallStewart Goldman

8:00am MDT

SIOPe DIPG Registry Update Alhambra HallSophie Veldhuijzen van Zanten

8:15am MDT

International DIPG/DMG Registry Update Alhambra HallTrent Hummel

8:30am MDT

A Review of PBTC Initiatives for DIPG/DMG and Medulloblastoma Alhambra HallIra Dunkel

8:50am MDT

Reirradiation for DIPG: Common Practice but is it Ready for Standard of Care Alhambra HallKatherine Warren

9:25am MDT

Review of Current Funded Research Results and Progress Alhambra HallGavin Baumgardner Statistical Analysis and Trial Design - Sponsored by The Brooke Healy Foundation Alberta RoomFelicia Wilson

9:30am MDT

Translating Mechanism to Patient Benefit for ACVR1 Mutant DIPG Alhambra HallChris Jones

9:45am MDT

CSF Cell-Free Tumor DNA Liquid Biopsies Alhambra HallAlexandra Miller

10:00am MDT

Targeting Histone Lysine Demethylases to Treat DIPG Alhambra HallRichard Lu

10:15am MDT

Exploring Novel Targets in DIPG Alhambra HallBiplab Dasgupta

10:30am MDT

The Role of QPRT and NAD Pathways in DIPG Treatment Resistance Alhambra HallIan Pollack

10:45am MDT

Targeting Post-Translational Protein Modification to Halt DIPG Tumorgenicity Alhambra HallBenjamin Rayner Young Adult and Adult DIPG/DMG Focus Group (Invitation Only) Alberta Room

11:00am MDT

A Novel Formulation Targeting MYCN Expression and Copper Chelation to Treat DIPG Alhambra HallRiccardo Cazzoli

11:15am MDT

Enhancing the Recruitment of Tumor Infiltrating Lymphocytes to Improve DMG Therapies Alhambra HallMatthew Dun

11:30am MDT

DMG COMBATT 2.0 Alhambra HallRyan Duchatel

11:45am MDT

TarGeT Alhambra HallNicholas Gottardo

12:25pm MDT

Cure Fund Grant Presentation - Sponsored by SnapgrantGavin Baumgardner

12:30pm MDT

Exploiting U1 SNRNA Mutations to Create Synthetic Lethality in SHH Medulloblastoma Alhambra HallPablo Acera

12:35pm MDT

Monitoring Nanbody-Based B7H3 CAR-T Cell Behavior and Efficacy in DMG Alhambra HallEsther Hulleman

12:40pm MDT

Identification of Extracellular Vesicle MIRNAs as Novel Biomarkers and Therapeutic Targets for High Risk Medulloblastoma Alhambra HallRosa Mistica Ignacio

12:45pm MDT

Gas Marble Therapeutics for Brain Cancer Alhambra HallFrederic Zenhausern

12:50pm MDT

Summary of Cure Fund Presentations Alhambra Hall

12:55pm MDT

Review of Current Funded Research Results and Progress Alhambra HallGavin Baumgardner Family/Foundations Workshop - Sponsored by The Reflections of Grace Foundation Alberta RoomSteve Healey • Tamara Ekis

1:00pm MDT

SUMOylation as a Novel Target in DIPG Alhambra HallBiplab Dasgupta

1:15pm MDT

Targeting Macrophages to Improve Survival with DIPG Alhambra HallDolores Hambardzumyan

1:30pm MDT

Synthetic Lethality Screening with Methionine Restriction for DIPG Alhambra HallCynthia Hawkins

1:45pm MDT

Stave the Monster: Multi-Metabolic Treatment Strategies for H3.3K27M-Mutant DIPG/DMG Alhambra HallChristof Kramm

2:00pm MDT

Assessing the Potential of the HDAC Inhibitor Givinostat and Radiotherapy for the Treatment of DMG Alhambra HallEsther Hulleman

2:15pm MDT

Preclinical Evaluation of TP-0184 in an Autochthonous Mouse Model in DIPG Alhambra HallOren Becher

2:30pm MDT

Targeted Radiopharmaceutical Therapies for Pediatric Brain Tumors; TARGET-FIRST Alhambra HallSophie Veldhuijzen van Zanten

2:45pm MDT

Intranasal Delivery of Targeting Nanotherapeutics for DIPG Alhambra HallRintaro Hashizume

3:00pm MDT

FLASH Radiotherapy Alhambra HallAnthony Mascia

3:15pm MDT

Targeting DMG with Innovative T-Cell Immunotherapy Alhambra HallRichard Lu

3:45pm MDT

Snack Break - Sponsored by Reflections of Grace Foundation Lobby

4:00pm MDT

Therapeutic Showcase - Sponsored by The Cure Starts Now Australia Alhambra HallGavin Baumgardner

5:10pm MDT

Wrap Up Alhambra HallTamara Ekis • Gavin Baumgardner

6:15am MDT

Breakfast Available - Sponsored by The Brooke Healey Foundation Alhambra Hall Breakfast Available - Sponsored by The Brooke Healey Foundation Cascade/Conservatory Room

7:30am MDT

Registry Patterns and Trends; What is Missing Alhambra HallTrent Hummel Medulloblastoma ForumNicholas Gottardo

7:45am MDT

Posterior Fossa Syndrome Cascade/Conservatory RoomBarry Pizer

8:00am MDT

Review of Newly Funded DMG Research Concepts Alhambra HallGavin Baumgardner

8:05am MDT

Targeting DMG Vulnerabilities as a Therapeutic Strategy Alhambra HallMarta Alonso Imaging Features of Posterior Fossa SyndromeShivaram Avula

8:20am MDT

Understanding Tumor Heterogeneity in ACVR1-Mutated DMG Alhambra HallJerome Fortin

8:25am MDT

Neuro-Cognitive Function: The Met Med Trial Cascade/Conservatory RoomDonald Mabbott

8:35am MDT

Multilamellar H3K27M RNA Aggregates Targeting DMG Alhambra HallGene Hwang

8:45am MDT

Neuro-Cognitive Rehabilitation and Interventions at St Jude Cascade/Conservatory RoomHeather Conklin

8:50am MDT

Targeting Lactate Production Pathways as a Novel Therapy Against DIPG Alhambra HallJessica Bell

9:05am MDT

Cytokine Signaling in DMG to Enhance GD2-Directed CAR T Cell Trafficking Alhambra Hall The St. Jude Experience Cascade/Conservatory RoomGiles Robinson

9:20am MDT

Leveraging Epigenetic Alterations for Therapy of DMG Alhambra HallMichael Koldobskiy

9:25am MDT

Translating CSF Monitoring for Minimal Residual Disease Monitoring to the Clinic Cascade/Conservatory RoomAnthony Liu

9:35am MDT

CXCR1/2 Signaling Pathway: a Role in the Invasive Mechanism of DIPG Alhambra HallOded Behar

9:45am MDT

The COG Experience Cascade/Conservatory RoomNicholas Gottardo

10:05am MDT

Leveraging Open Science and Collaboration to Identify Clinical Quality ALK2 Inhibitors for DIPG Alhambra HallDavid Drewry

10:15am MDT

Medulloblastoma Forum SummaryAmar Gajjar

10:20am MDT

Unlocking the Potential of the Blood-Brain Barrier Alhambra HallMaria Tsoli

10:35am MDT

Summary of Newly Funded DMG Research Concepts Alhambra HallGavin Baumgardner

10:50am MDT

Coffee and Tea Break - Sponsored by Choose Joy for Melina

11:00am MDT

Review of Current Funded Research Results and Progress Alhambra HallGavin Baumgardner

Need help? View Support Guides
Event questions? Contact Event Planner

Powered by Sched Event Planning App

©2025 Sched • About • Privacy • Terms